A detailed history of Comgest Global Investors S.A.S. transactions in Eli Lilly & CO stock. As of the latest transaction made, Comgest Global Investors S.A.S. holds 574,242 shares of LLY stock, worth $457 Million. This represents 8.07% of its overall portfolio holdings.

Number of Shares
574,242
Previous 712,803 19.44%
Holding current value
$457 Million
Previous $645 Million 21.17%
% of portfolio
8.07%
Previous 10.1%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$772.14 - $960.02 $107 Million - $133 Million
-138,561 Reduced 19.44%
574,242 $509 Million
Q2 2024

Aug 01, 2024

SELL
$724.87 - $909.04 $22.6 Million - $28.3 Million
-31,172 Reduced 4.19%
712,803 $645 Million
Q1 2024

May 07, 2024

SELL
$592.2 - $792.28 $48.8 Million - $65.3 Million
-82,463 Reduced 9.98%
743,975 $579 Million
Q4 2023

Feb 12, 2024

SELL
$525.19 - $619.13 $24.5 Million - $28.9 Million
-46,650 Reduced 5.34%
826,438 $482 Million
Q3 2023

Nov 07, 2023

SELL
$434.7 - $599.3 $50.9 Million - $70.1 Million
-117,020 Reduced 11.82%
873,088 $469 Million
Q2 2023

Jul 24, 2023

SELL
$350.74 - $468.98 $5.16 Million - $6.9 Million
-14,711 Reduced 1.46%
990,108 $464 Million
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $21.8 Million - $25.6 Million
-70,206 Reduced 6.53%
1,004,819 $345 Million
Q4 2022

May 15, 2023

SELL
$321.55 - $374.67 $59.8 Million - $69.6 Million
-185,874 Reduced 14.74%
1,075,025 $393 Million
Q4 2022

Feb 10, 2023

SELL
$321.55 - $374.67 $59.8 Million - $69.6 Million
-185,874 Reduced 14.74%
1,075,025 $393 Million
Q3 2022

May 15, 2023

SELL
$296.48 - $337.87 $5.54 Million - $6.32 Million
-18,691 Reduced 1.46%
1,260,899 $408 Million
Q3 2022

Nov 10, 2022

SELL
$296.48 - $337.87 $5.54 Million - $6.32 Million
-18,691 Reduced 1.46%
1,260,899 $408 Million
Q2 2022

May 15, 2023

SELL
$278.73 - $327.27 $55.4 Million - $65.1 Million
-198,842 Reduced 13.45%
1,279,590 $415 Million
Q2 2022

Jul 28, 2022

SELL
$278.73 - $327.27 $55.4 Million - $65.1 Million
-198,842 Reduced 13.45%
1,279,590 $415 Million
Q1 2022

May 15, 2023

BUY
$234.69 - $291.66 $111 Million - $138 Million
473,613 Added 47.13%
1,478,432 $423 Million
Q1 2022

May 13, 2022

SELL
$234.69 - $291.66 $13 Million - $16.2 Million
-55,397 Reduced 3.61%
1,478,432 $423 Million
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $844,986 - $1.05 Million
3,758 Added 0.25%
1,533,829 $424 Million
Q3 2021

Nov 02, 2021

SELL
$221.6 - $272.71 $23.4 Million - $28.9 Million
-105,809 Reduced 6.47%
1,530,071 $354 Million
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $20.3 Million - $26.2 Million
-112,327 Reduced 6.43%
1,635,880 $375 Million
Q1 2021

May 14, 2021

BUY
$164.32 - $212.72 $13.9 Million - $18 Million
84,482 Added 5.08%
1,748,207 $327 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $11.1 Million - $14.6 Million
84,778 Added 5.37%
1,663,725 $281 Million
Q3 2020

Nov 13, 2020

BUY
$146.22 - $169.13 $44.6 Million - $51.5 Million
304,686 Added 23.91%
1,578,947 $234 Million
Q2 2020

Jul 31, 2020

SELL
$136.42 - $164.18 $13.4 Million - $16.1 Million
-98,095 Reduced 7.15%
1,274,261 $209 Million
Q1 2020

May 07, 2020

SELL
$119.05 - $147.35 $17.9 Million - $22.2 Million
-150,398 Reduced 9.88%
1,372,356 $190 Million
Q4 2019

Feb 13, 2020

SELL
$106.92 - $132.43 $5.66 Million - $7.01 Million
-52,946 Reduced 3.36%
1,522,754 $200 Million
Q3 2019

Nov 05, 2019

BUY
$106.79 - $116.16 $12.1 Million - $13.2 Million
113,400 Added 7.75%
1,575,700 $176 Million
Q2 2019

Aug 08, 2019

BUY
$110.79 - $129.32 $20.2 Million - $23.5 Million
182,100 Added 14.22%
1,462,300 $162 Million
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $38.1 Million - $44.8 Million
-341,900 Reduced 21.08%
1,280,200 $166 Million
Q4 2018

Feb 12, 2019

BUY
$105.9 - $118.64 $7.86 Million - $8.8 Million
74,200 Added 4.79%
1,622,100 $188 Million
Q3 2018

Nov 06, 2018

BUY
$85.86 - $107.31 $19.5 Million - $24.4 Million
227,200 Added 17.2%
1,547,900 $166 Million
Q2 2018

Aug 08, 2018

BUY
$75.7 - $86.88 $27.6 Million - $31.6 Million
364,200 Added 38.08%
1,320,700 $113 Million
Q1 2018

May 14, 2018

BUY
$74.21 - $87.6 $2.87 Million - $3.39 Million
38,700 Added 4.22%
956,500 $74 Million
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $3.74 Million - $4.02 Million
-45,700 Reduced 4.74%
917,800 $77.5 Million
Q3 2017

Nov 07, 2017

BUY
$77.07 - $85.54 $955,667 - $1.06 Million
12,400 Added 1.3%
963,500 $82.4 Million
Q2 2017

Aug 09, 2017

BUY
N/A
951,100
951,100 $78.3 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Comgest Global Investors S.A.S. Portfolio

Follow Comgest Global Investors S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Comgest Global Investors S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Comgest Global Investors S.A.S. with notifications on news.